Cargando…

Evidence supporting predicted metabolic pathways for Vibrio cholerae: gene expression data and clinical tests

Vibrio cholerae, the etiological agent of the diarrheal illness cholera, can kill an infected adult in 24 h. V.cholerae lives as an autochthonous microbe in estuaries, rivers and coastal waters. A better understanding of its metabolic pathways will assist the development of more effective treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jing, Romero, Pedro R., Schoolnik, Gary K., Spormann, Alfred M., Karp, Peter D.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458520/
https://www.ncbi.nlm.nih.gov/pubmed/16682451
http://dx.doi.org/10.1093/nar/gkl310
_version_ 1782127446609362944
author Shi, Jing
Romero, Pedro R.
Schoolnik, Gary K.
Spormann, Alfred M.
Karp, Peter D.
author_facet Shi, Jing
Romero, Pedro R.
Schoolnik, Gary K.
Spormann, Alfred M.
Karp, Peter D.
author_sort Shi, Jing
collection PubMed
description Vibrio cholerae, the etiological agent of the diarrheal illness cholera, can kill an infected adult in 24 h. V.cholerae lives as an autochthonous microbe in estuaries, rivers and coastal waters. A better understanding of its metabolic pathways will assist the development of more effective treatments and will provide a deeper understanding of how this bacterium persists in natural aquatic habitats. Using the completed V.cholerae genome sequence and PathoLogic software, we created VchoCyc, a pathway-genome database that predicted 171 likely metabolic pathways in the bacterium. We report here experimental evidence supporting the computationally predicted pathways. The evidence comes from microarray gene expression studies of V.cholerae in the stools of three cholera patients [D. S. Merrell, S. M. Butler, F. Qadri, N. A. Dolganov, A. Alam, M. B. Cohen, S. B. Calderwood, G. K. Schoolnik and A. Camilli (2002) Nature, 417, 642–645.], from gene expression studies in minimal growth conditions and LB rich medium, and from clinical tests that identify V.cholerae. Expression data provide evidence supporting 92 (53%) of the 171 pathways. The clinical tests provide evidence supporting seven pathways, with six pathways supported by both methods. VchoCyc provides biologists with a useful tool for analyzing this organism's metabolic and genomic information, which could lead to potential insights into new anti-bacterial agents. VchoCyc is available in the BioCyc database collection ().
format Text
id pubmed-1458520
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-14585202006-05-12 Evidence supporting predicted metabolic pathways for Vibrio cholerae: gene expression data and clinical tests Shi, Jing Romero, Pedro R. Schoolnik, Gary K. Spormann, Alfred M. Karp, Peter D. Nucleic Acids Res Article Vibrio cholerae, the etiological agent of the diarrheal illness cholera, can kill an infected adult in 24 h. V.cholerae lives as an autochthonous microbe in estuaries, rivers and coastal waters. A better understanding of its metabolic pathways will assist the development of more effective treatments and will provide a deeper understanding of how this bacterium persists in natural aquatic habitats. Using the completed V.cholerae genome sequence and PathoLogic software, we created VchoCyc, a pathway-genome database that predicted 171 likely metabolic pathways in the bacterium. We report here experimental evidence supporting the computationally predicted pathways. The evidence comes from microarray gene expression studies of V.cholerae in the stools of three cholera patients [D. S. Merrell, S. M. Butler, F. Qadri, N. A. Dolganov, A. Alam, M. B. Cohen, S. B. Calderwood, G. K. Schoolnik and A. Camilli (2002) Nature, 417, 642–645.], from gene expression studies in minimal growth conditions and LB rich medium, and from clinical tests that identify V.cholerae. Expression data provide evidence supporting 92 (53%) of the 171 pathways. The clinical tests provide evidence supporting seven pathways, with six pathways supported by both methods. VchoCyc provides biologists with a useful tool for analyzing this organism's metabolic and genomic information, which could lead to potential insights into new anti-bacterial agents. VchoCyc is available in the BioCyc database collection (). Oxford University Press 2006 2006-05-08 /pmc/articles/PMC1458520/ /pubmed/16682451 http://dx.doi.org/10.1093/nar/gkl310 Text en © The Author 2006. Published by Oxford University Press. All rights reserved
spellingShingle Article
Shi, Jing
Romero, Pedro R.
Schoolnik, Gary K.
Spormann, Alfred M.
Karp, Peter D.
Evidence supporting predicted metabolic pathways for Vibrio cholerae: gene expression data and clinical tests
title Evidence supporting predicted metabolic pathways for Vibrio cholerae: gene expression data and clinical tests
title_full Evidence supporting predicted metabolic pathways for Vibrio cholerae: gene expression data and clinical tests
title_fullStr Evidence supporting predicted metabolic pathways for Vibrio cholerae: gene expression data and clinical tests
title_full_unstemmed Evidence supporting predicted metabolic pathways for Vibrio cholerae: gene expression data and clinical tests
title_short Evidence supporting predicted metabolic pathways for Vibrio cholerae: gene expression data and clinical tests
title_sort evidence supporting predicted metabolic pathways for vibrio cholerae: gene expression data and clinical tests
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458520/
https://www.ncbi.nlm.nih.gov/pubmed/16682451
http://dx.doi.org/10.1093/nar/gkl310
work_keys_str_mv AT shijing evidencesupportingpredictedmetabolicpathwaysforvibriocholeraegeneexpressiondataandclinicaltests
AT romeropedror evidencesupportingpredictedmetabolicpathwaysforvibriocholeraegeneexpressiondataandclinicaltests
AT schoolnikgaryk evidencesupportingpredictedmetabolicpathwaysforvibriocholeraegeneexpressiondataandclinicaltests
AT spormannalfredm evidencesupportingpredictedmetabolicpathwaysforvibriocholeraegeneexpressiondataandclinicaltests
AT karppeterd evidencesupportingpredictedmetabolicpathwaysforvibriocholeraegeneexpressiondataandclinicaltests